Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Résultat
de votre recherche par promoteur : Abbott GmbH & Co. KG (Abbott)
Femme et Homme Max 99 ans
Abbott GmbH & Co. KG (Abbott)
MAJ Il y a 4 ans
A Multi-Center, Open-Label Study of the Fully Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Moderate to Severe Crohn's Disease
To evaluate and delineate the safety and efficacy profile of adalimumab (HUMIRA pre-filled syringe or HUMIRA pre-filled PEN) when administered to subjects with moderate to severe Crohn´s Disease.
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Essai clos aux inclusions
Plus d'informations
Femme et Homme Max 99 ans
Abbott GmbH & Co. KG (Abbott)
MAJ Il y a 4 ans
A study of the efficacy and safety of adalimumab in pediatric subjects with enthesitis related arthritis
The objectives of this study are to evaluate the efficacy and safety of adalimumab given subcutaneously every other week (eow) as compared to placebo in pediatric subjects with Enthesitis Related Arth...
Pays
Aucun
Organes
Aucun
Spécialités
Aucune
Plus d'informations